Bruker Corporation (NASDAQ:BRKR) Receives Average Recommendation of “Hold” from Brokerages

Shares of Bruker Corporation (NASDAQ:BRKR) have received a consensus recommendation of “Hold” from the fifteen analysts that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $51.3077.

A number of research analysts recently issued reports on BRKR shares. The Goldman Sachs Group reduced their price objective on Bruker from $40.00 to $35.00 and set a “sell” rating for the company in a research report on Friday, February 13th. Wall Street Zen raised Bruker from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Wolfe Research initiated coverage on Bruker in a research note on Monday, June 1st. They set a “peer perform” rating on the stock. JPMorgan Chase & Co. lifted their target price on Bruker from $55.00 to $65.00 and gave the company an “overweight” rating in a research note on Monday, June 8th. Finally, Barclays lifted their target price on Bruker from $45.00 to $53.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th.

Insiders Place Their Bets

In other Bruker news, VP Mark Munch sold 2,000 shares of Bruker stock in a transaction on Wednesday, April 15th. The stock was sold at an average price of $39.90, for a total transaction of $79,800.00. Following the sale, the vice president owned 128,443 shares of the company’s stock, valued at $5,124,875.70. The trade was a 1.53% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 27.20% of the stock is owned by insiders.

Institutional Trading of Bruker

Hedge funds have recently added to or reduced their stakes in the business. Los Angeles Capital Management LLC bought a new stake in Bruker during the 4th quarter valued at $26,000. Parallel Advisors LLC raised its stake in shares of Bruker by 121.0% in the 4th quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock worth $41,000 after buying an additional 479 shares in the last quarter. Allworth Financial LP raised its stake in shares of Bruker by 40.6% in the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after buying an additional 257 shares in the last quarter. Essential Partners LLC bought a new stake in shares of Bruker in the 1st quarter worth $36,000. Finally, Summit Securities Group LLC bought a new stake in shares of Bruker in the 4th quarter worth $50,000. Institutional investors own 79.52% of the company’s stock.

Bruker Trading Down 1.7%

NASDAQ:BRKR opened at $54.23 on Friday. Bruker has a 12-month low of $28.53 and a 12-month high of $64.54. The firm has a market capitalization of $8.26 billion, a P/E ratio of -225.96, a P/E/G ratio of 1.77 and a beta of 1.31. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.55 and a quick ratio of 0.72. The business has a 50 day simple moving average of $44.62 and a 200 day simple moving average of $43.86.

Bruker (NASDAQ:BRKR) last released its quarterly earnings data on Wednesday, May 6th. The medical research company reported $0.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.08. Bruker had a positive return on equity of 11.60% and a negative net margin of 0.65%.The business had revenue of $823.40 million during the quarter, compared to analyst estimates of $795.62 million. During the same quarter in the previous year, the firm posted $0.47 EPS. The business’s revenue for the quarter was up 2.7% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Equities research analysts predict that Bruker will post 2.12 EPS for the current year.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 7th. Shareholders of record on Monday, June 22nd will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Monday, June 22nd. This represents a $0.20 annualized dividend and a yield of 0.4%. Bruker’s payout ratio is presently -83.33%.

About Bruker

Bruker Corporation, founded in 1960 by physicist Günther Laukien and headquartered in Billerica, Massachusetts, is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions. The company designs systems that enable molecular and materials research across academic, governmental, and industrial laboratories.

Bruker’s product portfolio encompasses nuclear magnetic resonance (NMR) spectrometers for molecular structure and dynamics studies, mass spectrometry platforms for proteomics and metabolomics, X-ray diffraction and scattering instruments for crystallography and materials characterization, atomic force and scanning probe microscopes for nanoscale surface analysis, as well as preclinical imaging systems such as micro-CT and MRI scanners.

In addition to hardware, Bruker provides software suites, applications support, training services, and long-term maintenance agreements to ensure optimal instrument performance.